A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome

NCT00774007 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: mesalazine
DRUG: placebo

Sponsor

SOFAR S.p.A.

Collaborators

[object Object]